V3 serotyping of HIV-1 infection: correlation with genotyping and limitations.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology

• Publication date

  1999-04-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/00042560-199904150-00004PMID 10225224
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Multiple HIV-1 subtypes present amongst heterosexuals in Amsterdam 1988-1996: no evidence for spread of non-B subtypes.

  1998cited by this paper
• HIV Type 1 V3 Serotyping of Tanzanian Samples: Probable Reasons for Mismatching with Genetic Subtyping

  1998cited by this paper
• HIV‐1 genetic subtype A/B recombinant strain causing an explosive epidemic in injecting drug users in Kaliningrad

  1998cited by this paper
• Extent of Antigenic Diversity in the V3 Region of the Surface Glycoprotein, gp120, of Human Immunodeficiency Virus Type 1 Group M and Consequences for Serotyping

  1998cited by this paper
• Extreme founder effect in an HIV type 1 subtype A epidemic among drug users in Svetlogorsk, Belarus.

  1998cited by this paper
• Sequence Note: Extreme Founder Effect in an HIV Type 1 Subtype A Epidemic among Drug Users in Svetlogorsk, Belarus

  1998cited by this paper
• Serotyping of HIV Type 1 Infections: Definition, Relationship to Viral Genetic Subtypes, and Assay Evaluation

  1998cited by this paper
• Diagnosis of central nervous system complications in HIV-infected patients: cerebrospinal fluid analysis by the polymerase chain reaction.

  1997cited by this paper
• Presence of multiple non‐B subtypes and divergent subtype B strains of HIV‐1 in individuals infected after overseas deployment

  1997cited by this paper
• Increasing diversity of HIV‐1M serotypes in French blood donors over a 10‐year period (1985–1995)

  1997cited by this paper
• HIV Type 1 Subtype F Sequences in Romanian Children and Adults

  1997cited by this paper
• HIV Type 1 Diversity in Northern Paris, France

  1996cited by this paper
• Correlation of genetic and serologic approaches to HIV-1 subtyping in Thailand.

  1996cited by this paper
• Longstanding presence in Belgians of multiple non-B HIV-1 subtypes.

  1996cited by this paper
• Diversity of Antibody Binding to V3 Peptides Representing Consensus Sequences of HIV Type 1 Genotypes A to E: An Approach for HIV Type 1 Serological Subtyping

  1996cited by this paper
• Diverse HIV-1 genetic subtypes in UK.

  1996cited by this paper
• Presence of HIV-1 subtypes B and F and HTLV-I in HIV/HTLV coinfected individuals of Martinique.

  1996cited by this paper
• Biological consequences of human immunodeficiency virus type 1 envelope polymorphism: does variation matter? 1995 Fleming Lecture.

  1996cited by this paper
• HIV-1 subtype B in west Africa.

  1996cited by this paper
• First Case of HIV‐1 Group O Infection in Spain

  1996cited by this paper
• Genetic Heterogeneity of HIV Type 1 in Russia: Identification of H Variants and Relationship with Epidemiological Data

  1996cited by this paper
• HIV-1 group O infection in the USA

  1996cited by this paper
• Epidemiologic and evolutionary relationships between Romanian and Brazilian HIV-subtype F strains.

  1995cited by this paper
• Differential Role of V3-Specific Antibodies in Neutralization Assays Involving Primary and Laboratory-Adapted Isolates of HIV Type 1

  1995cited by this paper
• Variability of human immunodeficiency virus type 1 group O strains isolated from Cameroonian patients living in France

  1995cited by this paper
• HIV-1 Subtype A in Canada

  1995cited by this paper
• Determination of HIV‐1 subtypes in injecting drug users in Bangkok, Thailand, using peptide‐binding enzyme immunoassay, and heteroduplex mobility assay: evidence of increasing infection with HIV‐1 subtype E

  1995cited by this paper
• HIV-1 subtype C in China.

  1995cited by this paper
• Multiple introductions of HIV-1 subtype E into the western hemisphere.

  1995cited by this paper
• Detection of diverse HIV-1 genetic subtypes in the USA.

  1995cited by this paper
• Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays

  1994cited by this paper
• Genetic and Phylogenetic Analysis of env Subtypes G and H in Central Africa

  1994cited by this paper
• Reactions of Ugandan Antisera with Peptides Encoded by V3 Loop Epitopes of Human Immunodeficiency Virus Type 1

  1994cited by this paper
• CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.

  1994cited by this paper
• Identification of an env G subtype and heterogeneity of HIV‐1 strains in the Russian Federation and Belarus

  1994cited by this paper
• Genotypic subtypes of HIV‐1 in Cameroon

  1994cited by this paper
• Genetic analysis of human immunodeficiency virus type 1 and 2 (HIV-1 and HIV-2) mixed infections in India reveals a recent spread of HIV-1 and HIV-2 from a single ancestor for each of these viruses

  1994cited by this paper
• Mutational trends in V3 loop protein sequences observed in different genetic lineages of human immunodeficiency virus type 1

  1994cited by this paper
• Serotyping HIV Type 1 by Antibody Binding to the V3 Loop: Relationship to Viral Genotype

  1994cited by this paper
• Antigenic Variation and Serotyping of HIV Type 1 from Four World Health Organization-Sponsored HIV Vaccine Sites

  1994cited by this paper
• HIV-1 Sequence Subtype D in the United States

  1994cited by this paper
• Rapid grouping of HIV-1 infection in subtypes A to E by V3 peptide serotyping and its relation to sequence analysis.

  1994cited by this paper
• Reduced rate of disease development after HIV-2 infection as compared to HIV-1.

  1994cited by this paper
• Specialist domiciliary care in Australia

  1994cited by this paper
• HIV-1 subtype C in Brazil.

  1994cited by this paper
• Human Retroviruses and AIDS. A compilation and analysis of nucleic acid and amino acid sequences: I--II; III--V

  1993cited by this paper
• Independent introduction of two major HIV-1 genotypes into distinct high-risk populations in Thailand.

  1993cited by this paper
• Diversity of V3 Region Sequences of Human Immunodeficiency Viruses Type 1 from the Central African Republic

  1993cited by this paper
• Crystal structure of a human immunodeficiency virus type 1 neutralizing antibody, 50.1, in complex with its V3 loop peptide antigen.

  1993cited by this paper
• Greater diversity of the HIV-1 V3 neutralization domain in Tanzania compared with The Netherlands: serological and genetic analysis.

  1993cited by this paper
• Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes.

  1993cited by this paper
• Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody

  1992cited by this paper
• Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants.

  1992cited by this paper
• Production of site-selected neutralizing human monoclonal antibodies against the third variable domain of the human immunodeficiency virus type 1 envelope glycoprotein.

  1991cited by this paper
• Complete nucleotide sequence of the AIDS virus, HTLV-III

  1985cited by this paper
• Solid phase peptide synthesis. I. the synthesis of a tetrapeptide

  1963cited by this paper

• Recombinant Viruses Initiated the Early HIV-1 Epidemic in Burkina Faso

  2014cites this paper
• Characteristics of Patients Recently Infected with HIV-1 Non-B Subtypes in France: a Nested Study within the Mandatory Notification System for New HIV Diagnoses

  2014cites this paper
• Continuous Spread of HIV-1 Subtypes D and CRF01_AE in France from 2003 to 2009

  2012cites this paper
• An altered and more efficient mechanism of CCR5 engagement contributes to macrophage tropism of CCR5-using HIV-1 envelopes.

  2010cites this paper
• HIV-1 subtypes in pregnant women in the UK

  2007cites this paper
• Monitoring the dynamics of the HIV epidemic using assays for recent infection and serotyping among new HIV diagnoses: experience after 2 years in France.

  2007influential citation
• High specificity of V3 serotyping among human immunodeficiency virus type‐1 subtype C infected patients with varying disease status and viral phenotype

  2006cites this paper
• Analysis of the Antibody Response to an Immunodominant Epitope of the Envelope Glycoprotein of a Lentivirus and Its Diagnostic Potential

  2006influential citation
• Human immunodeficiency virus serotyping on dried serum spots as a screening tool for the surveillance of the AIDS epidemic

  2006cites this paper
• Development and Validation of an Immunoassay for Identification of Recent Human Immunodeficiency Virus Type 1 Infections and Its Use on Dried Serum Spots

  2005cites this paper
• Impact of Human Immunodeficiency Virus Type 1 Subtype on First-Line Antiretroviral Therapy Effectiveness

  2005cites this paper
• Host‐Dependent Serum Specificity to the V3 Domain of HIV‐1

  2004cites this paper
• Two Percent of HIV-Positive U.S. Blood Donors Are Infected with Non-subtype B Strains

  2003cites this paper
• HIV-1 Subtypes and Recombinants

  2002cites this paper
• Serotyping HIV-1 with V3 peptides: detection of high avidity antibodies presenting clade-specific reactivity.

  2002cites this paper
• Monitoring HIV-1 Subtype Distribution

  2002cites this paper
• Development and Evaluation of a DNA Enzyme Immunoassay Method for env Genotyping of Subtypes A through G of Human Immunodeficiency Virus Type 1 Group M, with Discrimination of the Circulating Recombinant Forms CRF01_AE and CRF02_AG

  2002cites this paper
• One-Tube Real-Time Isothermal Amplification Assay To Identify and Distinguish Human Immunodeficiency Virus Type 1 Subtypes A, B, and C and Circulating Recombinant Forms AE and AG

  2001cites this paper
• The public health significance of HIV-1 subtypes

  2001cites this paper
• V3 Serological Subtyping of Human Immunodeficiency Virus Type 2 Infection Is Not Relevant

  2001cites this paper
• Human immunodeficiency virus type 1 subtype E envelope recombinant peptides containing naturally immunogenic epitopes.

  2000cites this paper
• B-cell epitopes of the envelope glycoprotein of caprine arthritis-encephalitis virus and antibody response in infected goats.

  2000cites this paper
• Molecular evolution of human immunodeficiency virus type 1 subtype A in Senegal: 1988-1997.

  2000cites this paper
• Interaction with human immunodeficiency virus (HIV) type 2 predicts HIV type 1 genotype.

  2000cites this paper
• Serotyping of HIV Type 1 Infections: Definition, Relationship to Viral Genetic Subtypes, and Assay Evaluation

  1998cites this paper
• HIV Type 1 V3 Serotyping of Tanzanian Samples: Probable Reasons for Mismatching with Genetic Subtyping

  1998cites this paper
• Sequence Note: Extreme Founder Effect in an HIV Type 1 Subtype A Epidemic among Drug Users in Svetlogorsk, Belarus

  1998cites this paper